Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMID 19330385)

Published in Mol Imaging Biol on March 28, 2009

Authors

S T Lee1, M Ghanem, R A Herbertson, S U Berlangieri, A J Byrne, K Tabone, P Mitchell, S R Knight, M Feigen, A M Scott

Author Affiliations

1: Centre for PET, Austin Health, Heidelberg, Victoria, Australia. szeting.lee@austin.org.au

Articles by these authors

Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biol Rev Camb Philos Soc (1966) 17.89

Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell (1987) 14.62

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet (2007) 6.82

Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med (1997) 6.09

Functions of the exosome in rRNA, snoRNA and snRNA synthesis. EMBO J (1999) 5.68

Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology (1996) 5.36

Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06

The yeast exosome and human PM-Scl are related complexes of 3' --> 5' exonucleases. Genes Dev (1999) 4.95

Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31

Acid-base titration across the membrane system of rat-liver mitochondria. Catalysis by uncouplers. Biochem J (1967) 4.24

Proton-coupled beta-galactoside translocation in non-metabolizing Escherichia coli. J Bioenerg (1972) 4.24

Estimation of membrane potential and pH difference across the cristae membrane of rat liver mitochondria. Eur J Biochem (1969) 3.97

Computer-assisted follow-up register for the north-east of Scotland. Br Med J (1970) 3.92

Translocations through natural membranes. Adv Enzymol Relat Areas Mol Biol (1967) 3.77

Vectorial chemistry and the molecular mechanics of chemiosmotic coupling: power transmission by proticity. Biochem Soc Trans (1976) 3.58

Cooperative hernia study. Pain in the postrepair patient. Ann Surg (1996) 3.57

Performance and conservation of osmotic work by proton-coupled solute porter systems. J Bioenerg (1973) 3.41

Possible molecular mechanisms of the protonmotive function of cytochrome systems. J Theor Biol (1976) 3.41

Keilin's respiratory chain concept and its chemiosmotic consequences. Science (1979) 3.23

Translocation of some anions cations and acids in rat liver mitochondria. Eur J Biochem (1969) 3.13

The POP1 gene encodes a protein component common to the RNase MRP and RNase P ribonucleoproteins. Genes Dev (1994) 3.12

Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry (2001) 3.07

Chemiosmotic coupling in energy transduction: a logical development of biochemical knowledge. J Bioenerg (1972) 3.02

Proton-translocation phosphorylation in mitochondria, chloroplasts and bacteria: natural fuel cells and solar cells. Fed Proc (1967) 2.96

Proton/sodium ion antiport in Escherichia coli. Biochem J (1974) 2.89

Prevalence and causes of amblyopia in an adult population. Ophthalmology (1998) 2.84

Smoking and age-related macular degeneration: a review of association. Eye (Lond) (2005) 2.77

The polarity of proton translocation in some photosynthetic microorganisms. Eur J Biochem (1969) 2.74

Stoicheiometry of lactose-H+ symport across the plasma membrane of Escherichia coli. Biochem J (1973) 2.57

Visual impairment and falls in older adults: the Blue Mountains Eye Study. J Am Geriatr Soc (1998) 2.51

Degradation of ribosomal RNA precursors by the exosome. Nucleic Acids Res (2000) 2.47

Acid-base titration across the plasma membrane of Micrococcus denitrificans: factors affecting the effective proton conductance and the respiratory rate. J Bioenerg (1970) 2.45

Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J (2006) 2.34

The protonmotive Q cycle: a general formulation. FEBS Lett (1975) 2.32

Amitriptyline and cardiac disease. Risk of sudden death identified by monitoring system. Lancet (1970) 2.31

Refractive errors in an older population: the Blue Mountains Eye Study. Ophthalmology (1999) 2.29

A computer assisted follow-up register. Methods Inf Med (1969) 2.29

"Smoking is a major cause of blindness". Med J Aust (1999) 2.27

The Ninth Sir Hans Krebs Lecture. Compartmentation and communication in living systems. Ligand conduction: a general catalytic principle in chemical, osmotic and chemiosmotic reaction systems. Eur J Biochem (1979) 2.25

Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective. Diabetologia (2010) 2.23

Stoichiometry of proton translocation through the respiratory chain and adenosine triphosphatase systems of rat liver mitochondria. Nature (1965) 2.19

Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis. Am J Transplant (2012) 2.18

Respiration-driven proton translocation in Micrococcus denitrificans. J Bioenerg (1971) 2.17

Outdoor activity and myopia in Singapore teenage children. Br J Ophthalmol (2009) 2.13

Protonmotive redox mechanism of the cytochrome b-c1 complex in the respiratory chain: protonmotive ubiquinone cycle. FEBS Lett (1975) 2.07

Knowledge and beliefs about common eye diseases. Aust N Z J Ophthalmol (1997) 2.06

Medications and cataract. The Blue Mountains Eye Study. Ophthalmology (1998) 2.05

Validation of self-reported hearing loss. The Blue Mountains Hearing Study. Int J Epidemiol (2001) 2.00

Age-related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol (2008) 1.98

British Medical Association enters GM-crop affray. Lancet (1999) 1.94

Vision screening for frail older people: a randomised trial. Br J Ophthalmol (2008) 1.93

Clustering of modified nucleotides at the functional center of bacterial ribosomal RNA. FASEB J (1993) 1.93

Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol (2001) 1.92

Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol (2001) 1.88

Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care (2001) 1.84

Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol (1998) 1.84

Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J (1995) 1.82

Retinopathy predicts coronary heart disease mortality. Heart (2008) 1.80

The development of performance and cost indicators for preschool immunisation. Arch Dis Child (1986) 1.77

Adrenocortical suppression in multiply injured patients: a complication of etomidate treatment. Br Med J (Clin Res Ed) (1983) 1.74

Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody. J Nucl Med (2001) 1.70

Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol (1998) 1.70

Impact of visual impairment on use of community support services by elderly persons: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci (1999) 1.70

Propofol and ECT. Br J Psychiatry (1992) 1.68

Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry (1995) 1.67

Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol (1996) 1.67

Vectorial chemiosmotic processes. Annu Rev Biochem (1977) 1.66

Incidence of nursing home placement in a defined community. Med J Aust (2001) 1.65

The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology (2000) 1.64

The nature of bipolar depression: implications for the definition of melancholia. J Affect Disord (2000) 1.64

A method for the simultaneous measurement of insulin release and B cell membrane potential in single mouse islets of Langerhans. Diabetologia (1981) 1.63

Effects of cataract type and location on visual function: the Blue Mountains Eye Study. Eye (Lond) (2004) 1.62

Comparison of dobutamine echocardiography and positron emission tomography in patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol (1996) 1.61

Efficacy study of video-assisted thoracoscopic surgery pleurodesis for spontaneous pneumothorax. Ann Thorac Surg (2001) 1.59

Self-reported dark red bleeding as a marker comparable with occult blood testing in screening for large bowel neoplasms. Br J Surg (1983) 1.59

Covered expandable tracheal stents in the management of benign tracheal granulation tissue formation. Ann Thorac Surg (2000) 1.59

Proton translocation coupled to ATP hydrolysis in rat liver mitochondria. Eur J Biochem (1968) 1.57

Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma. Mol Immunol (1998) 1.56

Visual impairment, age-related cataract, and mortality. Arch Ophthalmol (2001) 1.55

Prevalence of pterygium and pinguecula: the Blue Mountains Eye Study. Aust N Z J Ophthalmol (1998) 1.53

Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection. J Immunother (2001) 1.52

Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor. Cancer Res (2001) 1.52

Microbes, peptic ulcer, and relapse rates with different drugs. Lancet (1984) 1.51

Renal impairment and anaemia in a population-based study of older people. Intern Med J (2004) 1.51

Cystadenomas of the liver: a spectrum of disease. Can J Surg (2001) 1.51

Retinal microvascular changes and subsequent vascular events after ischemic stroke. Neurology (2011) 1.49

The role of smart cards in France. Health Data Manag (1998) 1.49

Synthesis of adenosine triphosphate by a protonmotive force in rat liver mitochondria. Nature (1966) 1.48

Spinocerebellar ataxia type 2: clinical features of a pedigree displaying prominent frontal-executive dysfunction. Arch Neurol (1999) 1.48

Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR. Cancer Res (2001) 1.47

Chemiosmotic hypothesis of oxidative phosphorylation. Nature (1967) 1.47

Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study. Clin Experiment Ophthalmol (2000) 1.45

Study of cardiac rhythm in healthy newborn infants. Br Heart J (1980) 1.43

Does intra-arterial thrombolysis have a role as first-line intervention in acute ischaemic stroke? Intern Med J (2011) 1.43

Consequences of amblyopia on education, occupation, and long term vision loss. Br J Ophthalmol (2004) 1.42

Positron emission tomography scanning in the assessment of patients with lymphoma. Intern Med J (2004) 1.41

Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. J Clin Oncol (1994) 1.41

The proton-translocating ATPase of Escherichia coli. FEBS Lett (1974) 1.41